NLRP3 and Alzheimer disease: Hydrophobic interactions can increase the overall binding affinity of the ligand, which further stabilizes the binding of candidate compounds to target proteins, thus improving the binding ability to amino acid residues at the binding site and affecting the role of the candidate components in the TLR4/NFκB/NLRP3 inflammatory pathway, thereby inhibiting inflammation and improving AD.